Journals / Journal of advances in vetbio science and techniques / 2024 / Volume: 9 Issue: 3

Determination of the effects of vitamin D and Nettle (Urtica Dioica L) extract administration on SOD-2 and TNF-α levels in liver tissue of TNBS (2,4,6 Trinitrobenzene sulfonic acid)-induced rats

Şükran Aras(KAFKAS ÜNİVERSİTESİ)0000-0002-3267-5251
Pages
—
Publication Date
2024-12-27
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, it is thought that vitamin D and nettle extract may have positive effects on liver tissue and both substances may be protective against liver damage due to their antioxidant and anti-inflammatory effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to investigate the effects of vitamin D and nettle (Urtica dioica L.) extract on SOD-2 and TNF-α levels in liver tissue of rats induced with TNBS (2,4,6 Trinitrobenzene Sulfonic Acid) by immunohistochemical methods.
📊
Key Findings & Data:Strong SOD-2 immunoreactivity was detected in the cytoplasm of hepatocytes in control and TNBSD groups, weak in TNBS group and moderate in TNBSI group.
💡
Conclusion & Impact:In conclusion, it is thought that vitamin D and nettle extract may have positive effects on liver tissue and both substances may be protective against liver damage due to their antioxidant and anti-inflammatory effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vitamin D · nettle · liver

Abstract

The aim of this study was to investigate the effects of vitamin D and nettle (Urtica dioica L.) extract on SOD-2 and TNF-α levels in liver tissue of rats induced with TNBS (2,4,6 Trinitrobenzene Sulfonic Acid) by immunohistochemical methods. All rats used in the study were weighed and randomly divided into four groups. Liver tissue samples were taken at the end of the experiment. They were blocked in paraffin by applying routine tissue tracking procedure. Histologic and immunohistochemical methods were applied to the sections taken from the paraffin blocks. It was determined that histopathologic changes were intense in the TNBS group and less in the TNBSD and TNBSI groups. Strong SOD-2 immunoreactivity was detected in the cytoplasm of hepatocytes in control and TNBSD groups, weak in TNBS group and moderate in TNBSI group. TNF-α immunoreactivity was weak in the cytoplasm of hepatocytes in control group, strong in TNBS group, and moderate in TNBSD and TNBSI groups. In conclusion, it is thought that vitamin D and nettle extract may have positive effects on liver tissue and both substances may be protective against liver damage due to their antioxidant and anti-inflammatory effects.

🔖

Cite This Article

Aras, Ş. (2024). Determination of the effects of vitamin D and Nettle (Urtica Dioica L) extract administration on SOD-2 and TNF-α levels in liver tissue of TNBS (2,4,6 Trinitrobenzene sulfonic acid)-induced rats. Journal of advances in vetbio science and techniques, Volume: 9 Issue: 3. https://doi.org/10.31797/vetbio.1428195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (34)

  1. Abe, R.A.M., Masroor, A., Khorochkov, A., Prieto, J., Singh, K.B., Nnadozie, M.C., Abdal, M., Shrestha, N., & Mohammed, L. (2021). The role of vitamins in non-alcoholic fatty liver disease: A systematic review. Cureus, 13(8), 16855-16855. https://doi.org/10.7759/cureus.16855
  2. Beaman, L., & Beaman, BL. (1990). Monoclonal antibodies demonstrate that superoxide dismutase contributes to protection of Norcardia asteroides within intact host. Infection and Immunity, 58, 3122–3128. https://doi.org/10.1128/iai.58.9.3122-3128.1990
  3. Bechmann, L.P., Hannivoort, R.A., Gerken, G., Hotamisligil, G.S., Trauner, M., & Canbay, A. (2012). The interaction of hepatic lipid and glucose metabolism in liver diseases. Journal of Hepatology, 56(4), 952-964. https://doi.org/10.1016/j.jhep.2011. 08.025
  4. Bingül İ, Aydın AF, Küçükgergin C, Doğan-Ekici AI, Doğru-Abbasoğlu S, & Uysal M. (2021). The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease. Turkish Journal of Medical Sciences, 51, 1500-1511. https://doi.org/10.3906/sag-2007-289
  5. Bingül, İ., Aydın, A.F., Küçükgergin, C., Doğan-Ekici, I., Doğru-Abbasoğlu, S., & Uysal, M. (2021). The effect of vitamin D deficiency and 1,25(OH)2D3 treatment on oxidative stress and Nrf2-antioxidant signaling in ethanol-induced hepatotoxicity. Archives of Clinical and Experimental Medicine, 6(3), 127-133. https://doi.org/10.25000/acem.949073
  6. Bradley, J.R. (2008). TNF-Mediated inflammatory disease. Journal of Pathology, 214, 149-160. https://doi.org/10.1002/path.2287
  7. Connors, J., Dunn, K.A., Allott, J., Bandsma, R., Rashid, M., Otley, A.R., Bielawski J.P., & Limbergen, J.V. (2020). The relationship between fecal bile acids and microbiome community structure in pediatric Crohn’s disease. The ISME Journal, 14, 702–713. https://doi.org/10.1038/s41396-019-0560-3
  8. Del Pinto, R., Pietropaoli, D., Chandar, A.K., Ferri, C., & Cominelli, F. (2015). Association between inflammatory bowel disease and vitamin D deficiency: A systematic review and meta‑analysis. Inflammatory Bowel Diseases, 21, 2708‑2717. https://doi.org/10.1097/MIB.0000000000000546
  9. Fridovich, I. (1975). Superoxide dismutases. Annual Review of Biochemistry, 44, 147-159.
  10. Genc, Z., Yarat, A., Tunali-Akbay, T., Sener, G., Cetinel, S., Pisiriciler, R., Caliskan-Ak, E., Altıntas, A., & Demirci, B. (2011). The effect of stinging nettle (urtica dioica) seed oil on experimental colitis in rats. Journal of Medicinal Food, 14 (12): 1554–1561. https://doi.org/10.1089/jmf.2011.0028
  11. Gizard, E., Ford, A.C., Bronowicki, J.P., & Peyrin-Biroulet, L. (2014). Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 40, 3-15. https://doi.org/10.1111/apt.12794
  12. Hoan, N.X., Khuyen, N., Binh, M.T., Giang, D.P., Van Tong, H., Hoan, P.Q., Trung, N.T., Anh, D.T., Toan, N.L., Meyer, C.G., Kremsner, P.G., Velavan, T.P., & Song, L.H. (2016). Association of vitamin D deficiency with hepatitis B virus - related liver diseases. BMC Infectious Diseases, 16(1), 507. https://doi.org/10.1186/s12879-016-1836-0
  13. Hoşbaş, S. (2008). Urtica dioica L. bitkisi üzerinde farmakognozik araştırmalar (Tez No. 225730).[ Yüksek Lisans tezi, Gazi Üniversitesi].
  14. Ilkovska, B., Trifunova, B.K., Hristovska, S., & Ivanovska, M. (2019). Vitamin D levels in patients with chronic hepatitis b, chronic hepatitis c, and health controls. Journal of IMAB - Annual Proceeding (Scientific Papers), 25(2), 2553- 2558. https://doi.org/10.5272/jimab.2019252.2553
  15. Jamali, R., Biglari, M., Seyyed Hosseini, S.V., Shakouri Rad, A., & Kosari, F. (2017). The correlation between liver fat content and ulcerative colitis disease severity. Acta Medica Iranica, 55(5), 333–339.
  16. Kandis, H., Karapolat, S., Yildirim, U., Saritas, A., Gezer, S., & Memisogullari, R. (2010). Effects of Urtica dioica on hepatic ischemia-reperfusion injury in rats. Clinics (Sao Paulo), 65(12), 1357-1361. https://doi.org/10.1590/S1807-59322010001200021
  17. Kaplan, G.G., & Windsor, J.W. (2021). The four epidemiological stages in the global evolution of ınflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology, 18, 56–66. https://doi.org/10.1038/s41575-020-00360-x
  18. Larsen, S., Bendtzen, K., & Nielsen, O.H. (2010). Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Annals of Medicine, 42, 97–114. https://doi.org/10.3109/07853890903559724
  19. Lin, A., Roth, H., Anyane-Yeboa, A., Rubin, D.T., & Paul, S. (2021). Prevalence of nonalcoholic fatty liver disease in patients with ınflammatory bowel disease: A systematic review and meta-analysis. Inflammatory Bowel Disease, 27, 947–955. https://doi.org/10.1093/ibd/izaa189
  20. Magrì, S., Paduano, D., Chicco, F., Cingolani, A., Farris, C., Delogu, G., Tumbarello, F., Lai, M., Melis, A., Casula, L., Fantini, M.C., & Usai, P. (2019). Nonalcoholic fatty liver disease in patients with ınflammatory bowel disease: beyond the natural history. World Journal of Gastroenterology, 25, 5676–5686. https://doi.org/10. 3748/wjg.v25.i37.5676
  21. Mendes, F.D., Levy, C., Enders, F.B., Loftus, E.V., Jr, Angulo, P., & Lindor, K.D. (2007). Abnormal hepatic biochemistries in patients with inflammatory bowel disease. American Journal of Gastroenterology, 102, 344–350. https://doi.org/10.1111/j.1572-0241.2006.00947.x
  22. Mokhtari, Z., Hekmatdoost, A., & Nourian, M. (2017). Antioxidant efficacy of vitamin D. Journal of Parathyroid Disease, 5(1), 11-16.
  23. Özel, G.S.K., & Birdane, Y.O. (2014). Antioksidanlar. Kocatepe Veterinary Journal, 7(2), 41-52. https://doi.org/10.5578/kvj.8486
  24. Palmer, M.T., & Weaver, C.T. (2013). Linking vitamin D deficiency to inflammatory bowel disease. Inflammatory Bowel Diseases, 19(10), 2245-2256. https://doi.org/10.1097/MIB.0b013e31828a3b6f
  25. Rahman, A.H., & Branch, A.D. (2013). Vitamin D for your patients with chronic hepatitis C? Journal of Hepatology, 58(1), 184-189. https://doi.org/10.1016/j. jhep.2012.07.026
  26. Sentongo TA, Semaeo EJ, Stettler N, Piccoli, D.A., Stallings, V.A., & Zemel, B.S. (2002). Vitamin D status in children, adolescents, and young adults with Crohn disease. The American Journal of Clinical Nutrition, 76(5), 1077-1081. https://doi.org/10. 1093/ajcn/76.5.1077
  27. Suibhne, T.N., Cox, G., Healy, M., O'Morain, C., & O'Sullivan, M. (2012). Vitamin D deficiency in Crohn's disease: Prevalence, risk factors and supplement use in an outpatient setting. Journal of Crohn's and Colitis, 6(2), 182‑188. https://doi.org/10.1016/j.crohns.2011.08.002
  28. Sydor, S., Best, J., Messerschmidt, I., Manka, P., Vilchez-Vargas, R., Brodesser, S., Lucas, C., Wegehaupt, A., Wenning, C., Aßmuth, S., Hohenester, S., Link, A., Faber, K.N., Moshage, H., Cubero, F.J., Friedman, S.L., Gerken, G., Trauner, M., Canbay, A., & Bechmann, L.P. (2020). Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clinical and Translational Gastroenterology, 11(3), e00131. https://doi.org/10.14309/ctg.0000000000000131
  29. Şener, A., Gümüş, A., Göker, B., Arbak, S., Özsavcı, D., & Yurtsever, E. (2010). Isırgan Otu (Urtica dioica L.) Tohumu Ekstresinin Hepatoprotektif ve Antioksidatif Etkileri. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, 24(3), 167-172.
  30. Upton, R. (2013). Stinging nettles leaf (Urtica dioica L.): extraordinary vegetable medicine. Journal of Herbal Medicine, 3(1), 9-38. https://doi.org/10.1016/j.hermed.2012.11.001
  31. Xia, Y., Chen, H., Xiao, H., Yang, J., Li, Z., Wang, Y., Yang, T., & Wang, B. (2019). Immune regulation mechanism of vitamin D level and IL 17/IL 17R pathway in Crohn's disease. Experimental and Therapeutic Medicine, 17, 3423-3428. https://doi.org/10.3892/etm.2019.7389
  32. Yediel Aras, Ş., & Karadağ Sarı, E. (2021). An immunohistochemical examination of cinnamon extract administration on distribution of NGF (nerve growth factor) and Trk-A (tyrosine kinase-A) receptor for diabetic rats with pancreatic tissue. Turkish Journal of Medical Sciences, 51, 2771-2785. https://doi.org/10.3906/sag-2012-270
  33. Yener, Z., Celik, I., Ilhan, F., & Bal, R. (2009). Effects of Urtica dioica L. seed on lipid peroxidation, antioxidants and liver pathology in aflatoxin-induced tissue injury in rats. Food and Chemical Toxicology, 47(2), 418-424. https://doi.org/10.1016/j.fct. 2008.11.031
  34. Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E., (2018). Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology, 15(1), 11–20. https://doi.org/10.1038/nrgastro.2017.109